Article
Engineered hematopoietic stem cells give rise to therapeutic antibody secreting B cells
2026-04-06
Abstract excerpt
<title>Abstract</title> <p>Monoclonal antibodies represent half of the top ten selling drugs. Their proven efficacy, however, generally requires repeated administration for prolonged periods of time. In contrast, cell-based therapies offer a different set of pharmacokinetics and pharmacodynamics than traditional medicines, including the potential to have lifetime durability after a single infusion. Here, we descr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 020d4d83-e589-5bfa-86fc-9f794653a6b4
- DOI
- 10.21203/rs.3.rs-9269825/v1
